Variant report
Variant | esv3445012 |
---|---|
Chromosome Location | chr5:128327512-128328840 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:128327480..128330043-chr5:128331168..128333231,2 | K562 | blood: |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs564441686 | chr5:128327520-128327521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs17617329 | chr5:128327584-128327585 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs257907 | chr5:128327601-128327602 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs113454854 | chr5:128327606-128327607 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs184896277 | chr5:128327621-128327622 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs548336954 | chr5:128327636-128327637 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs116693705 | chr5:128327761-128327762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs549226670 | chr5:128327772-128327773 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs566137788 | chr5:128327820-128327821 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs7723102 | chr5:128327823-128327824 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
11 | rs535485424 | chr5:128327877-128327878 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs190929642 | chr5:128327880-128327881 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs547573187 | chr5:128327902-128327903 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs73784818 | chr5:128327909-128327910 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs139406154 | chr5:128327937-128327938 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs556475201 | chr5:128327970-128327971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs569581238 | chr5:128328082-128328083 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs550609714 | chr5:128328087-128328088 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs182009815 | chr5:128328089-128328090 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs555190688 | chr5:128328097-128328098 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs1181990 | chr5:128328165-128328166 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs369147526 | chr5:128328177-128328178 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs3851463 | chr5:128328182-128328183 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs759141 | chr5:128328213-128328214 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs759140 | chr5:128328219-128328220 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs529619737 | chr5:128328251-128328252 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187171718 | chr5:128328293-128328294 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs191988793 | chr5:128328332-128328333 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145712417 | chr5:128328333-128328334 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs183358725 | chr5:128328337-128328338 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs759139 | chr5:128328397-128328398 | Weak transcription Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs528636108 | chr5:128328405-128328406 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs188317607 | chr5:128328432-128328433 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs190124384 | chr5:128328443-128328444 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs34283563 | chr5:128328529-128328530 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs528454019 | chr5:128328588-128328589 | Weak transcription Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs564300825 | chr5:128328607-128328608 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs34379154 | chr5:128328668-128328669 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147767131 | chr5:128328687-128328688 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs533146039 | chr5:128328711-128328712 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs549819628 | chr5:128328755-128328756 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs885714 | chr5:128328768-128328769 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs12656532 | chr5:128328781-128328782 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs141141802 | chr5:128328782-128328783 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs372503191 | chr5:128328785-128328786 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs182298367 | chr5:128328826-128328827 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557418637 | chr5:128328839-128328840 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:128309600-128338200 | Weak transcription | Left Ventricle | heart |
2 | chr5:128320800-128328000 | Weak transcription | Placenta Amnion | Placenta Amnion |
3 | chr5:128321000-128335000 | Weak transcription | Fetal Heart | heart |
4 | chr5:128326600-128335000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr5:128326800-128327800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
6 | chr5:128327000-128328200 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
7 | chr5:128327400-128327800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
8 | chr5:128327800-128328000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
9 | chr5:128327800-128328200 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
10 | chr5:128328000-128329000 | Enhancers | Placenta Amnion | Placenta Amnion |
11 | chr5:128328200-128328600 | Strong transcription | Breast Myoepithelial Primary Cells | Breast |
12 | chr5:128328600-128330000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |